A 28-year-old man from Mumbai presents with acute onset of bilateral ptosis, ophthalmoplegia, and respiratory difficulty 2 hours after receiving an aminoglycoside antibiotic for a urinary tract infection. He has a known history of myasthenia gravis on pyridostigmine monotherapy. Bedside spirometry shows FVC 1.2 L (predicted 4.5 L). What is the most appropriate immediate next step?

Explanation

## Clinical Crisis Recognition This patient has **myasthenic crisis** — acute respiratory failure in a known MG patient precipitated by an **aminoglycoside antibiotic**, which is a known neuromuscular blocking agent. ### Diagnostic Criteria for Myasthenic Crisis **Key Point:** Myasthenic crisis is defined as acute respiratory failure requiring mechanical ventilation, typically triggered by: - **Infections** (respiratory, urinary, other) - **Medications** (aminoglycosides, fluoroquinolones, macrolides, beta-blockers, calcium channel blockers) - **Pregnancy and postpartum period** - **Surgery and anesthesia** - **Inadequate MG therapy** **High-Yield:** The FVC of 1.2 L (normal ≥ 2.5 L) indicates **severe restrictive respiratory impairment**. A patient with FVC < 1.5 L is at imminent risk of respiratory arrest and requires immediate airway management. ### Mechanism of Aminoglycoside-Induced Deterioration Aminoglycosides (gentamicin, tobramycin, amikacin) cause neuromuscular blockade by: 1. **Decreasing acetylcholine release** from the presynaptic terminal. 2. **Reducing acetylcholine receptor sensitivity** to ACh. 3. **Stabilizing the acetylcholinesterase-ACh complex**, reducing ACh availability. In MG patients, this compounds the existing deficiency of functional AChR, precipitating acute decompensation. ## Management Algorithm for Myasthenic Crisis ```mermaid flowchart TD A[Myasthenic Crisis Suspected]:::outcome --> B{Respiratory Compromise?}:::decision B -->|FVC < 1.5 L or RR > 30| C[Emergency Intubation]:::urgent B -->|FVC > 1.5 L, stable| D[Admit ICU, monitor closely]:::action C --> E[Secure airway, mechanical ventilation]:::action E --> F[Discontinue anticholinesterase]:::action F --> G[Start Plasmapheresis or IVIG]:::action D --> H[Identify and treat trigger]:::action H --> I[Plasmapheresis or IVIG]:::action G --> J[Recovery over 2-4 weeks]:::outcome I --> J ``` **Clinical Pearl:** The **edrophonium (Tensilon) test** is contraindicated in crisis because it can worsen respiratory failure. Similarly, anticholinesterase agents may paradoxically worsen crisis ("cholinergic crisis" risk), so they are **discontinued** during acute management. ## Why Immediate Intubation? 1. **FVC 1.2 L is critically low** — respiratory arrest is imminent. 2. **Rapid deterioration** in a known MG patient with a clear precipitant. 3. **Airway protection** is the priority before any other intervention. 4. **Guideline standard:** Intubation is indicated when FVC < 1.5 L or when clinical signs of respiratory distress are present [cite:Harrison 21e Ch 385]. ## Post-Intubation Management Once airway is secured: - **Discontinue pyridostigmine** (may worsen crisis). - **Remove the trigger** (stop aminoglycoside immediately). - **Start plasmapheresis or IVIG** within 24–48 hours to remove circulating anti-AChR antibodies and restore neuromuscular transmission. - **Corticosteroids** are started after crisis is controlled (not acutely, as they may transiently worsen symptoms). - **Mechanical ventilation** is typically needed for 2–4 weeks until antibody levels fall and neuromuscular function recovers.